Paper Details

  1. Home
  2. Paper Details

Treatment of recurrent genital herpes simplex infections with oral acyclovir.

Author: AnderssonB, ErikssonG, HersleK, HillströmL, LövhagenG B, MobackenH, Ruhnek-ForsbeckM, SandströmE, SvenssonL

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Controlled Clinical TrialA clinical trial that evaluates the effectiveness of a treatment by comparing a group that receives the intervention with a group that receives a placebo or standard treatment.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

A study of 113 patients with recurrent genital herpes found that acyclovir significantly reduced the duration of herpes outbreaks compared to placebo. Acyclovir shortened the time to crusting and healing, as well as the duration of symptoms and new lesions. Acyclovir was well-tolerated with no significant side effects. The study suggests that early treatment with acyclovir may stop herpes outbreaks before they progress to more severe stages.
Paper Details　
Original Abstract of the Article :
A total of 113 patients with recurrent genital herpes were enrolled in a multicentre cross-over study. Two consecutive recurrences were treated with either oral acyclovir 200 mg or matching placebo five times daily for five days. Acyclovir significantly reduced the time to crusting and healing and t...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1093/jac/16.5.621

データ提供：米国国立医学図書館（NLM）

Fighting Recurrent Genital Herpes: Acyclovir Shows Its Strength

This study tackles the challenge of recurrent genital herpes, a common viral infection that can cause significant discomfort and inconvenience. Think of recurrent herpes as a pesky sandstorm that keeps blowing in, interrupting a camel caravan's peaceful journey across the desert. The researchers evaluated the effectiveness of oral acyclovir in treating recurrent genital herpes, comparing it to a placebo. The results showed that acyclovir significantly reduced the time to healing and the duration of symptoms.

Acyclovir's Efficacy: A Speedy Recovery

The study revealed that acyclovir effectively shortened the healing time and symptom duration, allowing individuals to get back on their feet faster. This is like a camel caravan encountering a sandstorm, but with the help of a protective barrier (acyclovir), it can weather the storm and continue its journey more quickly.

Managing Herpes: A Tool for Better Health

This study emphasizes the importance of early self-treatment for recurrent genital herpes. By taking acyclovir as soon as symptoms appear, individuals can potentially prevent the infection from progressing to a more severe stage. This is like a camel caravan taking precautions against a sandstorm: early action can prevent a more serious situation. The research provides valuable insight into the management of recurrent genital herpes, empowering individuals to take control of their health and live more comfortably.

Dr.Camel's Conclusion

This study highlights the effectiveness of acyclovir in treating recurrent genital herpes, offering a potential solution to a common and often uncomfortable problem. By taking acyclovir at the first sign of symptoms, individuals can reduce the duration of the infection and minimize its impact on their lives. This is a great example of how medicine can help us navigate the challenges of life, much like a camel caravan navigating a sandstorm.

Date :
  1. Date Completed 1986-02-20
  2. Date Revised 2019-05-11
Further Info :

Pubmed ID

3908435

DOI: Digital Object Identifier

10.1093/jac/16.5.621

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.